Agent for treating myelofibrosis

Details Agent for treating myelofibrosis Agent for treating myelofibrosis

A - Human Necessities

61

K

A61K 47/10 (2006.01) A61K 9/127 (2006.01) A61K 31/7105 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) A61P 7/00 (2006.01) A61P 19/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2735709

Disclosed is a substance delivery carrier for an extracellular-matrix- producing cell in the bone marrow, which comprises a retinoid. Also disclosed is an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular-matrix-producing cell in the bone marrow.

L'invention porte sur un support d'administration de substance pour une cellule produisant de la matrice extracellulaire dans la moelle osseuse, qui comprend une rétinoïde. L'invention porte également sur un agent de traitement d'une myélofibrose à l'aide d'une substance capable de réguler l'activité ou la prolifération d'une cellule produisant de la matrice extracellulaire dans la moelle osseuse.

Affiliated with

Also associated with

Rating

Agent for treating myelofibrosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treating myelofibrosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating myelofibrosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1505748